NewLink says FDA allows human testing of Ebola vaccine

Sept 4 Thu Sep 4, 2014 7:28am EDT

Sept 4 (Reuters) - NewLink Genetics Corp said the U.S. Food and Drug Administration allowed the company to start testing an experimental Ebola vaccine in humans.

The vaccine, developed by Canadian government scientists, has been licensed to the company. (Reporting by Natalie Grover in Bangalore; Editing by Saumyadeb Chakrabarty)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.